_id
695fbb66c2e91020a7bd435e
Ticker
0K3W.LSE
Name
Myriad Genetics Inc.
Exchange
LSE
Address
322 North 2200 West, Salt Lake City, UT, United States, 84116
Country
UK
Sector
Industry
Currency
USD
Website
https://www.myriad.com
Description
Myriad Genetics, Inc., a molecular diagnostic company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and internationally. The company offers myRisk Hereditary Cancer, a DNA sequencing test for hereditary cancers; BRACAnalysis, a DNA sequencing test to assess the risk of developing breast and ovarian cancer; and riskScore, a personalized medicine tool. It also provides BRACAnalysis CDx, a DNA sequencing test for use in identifying ovarian and HER2 negative metastatic breast cancer patients with deleterious or suspected deleterious germline; GeneSight, a DNA genotyping test to aid psychotropic drug selection for depressed patients; and Vectra, a protein quantification test for assessing the disease activity of rheumatoid arthritis. In addition, the company offers Foresight, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; Prequel, a non-invasive prenatal screening test to screen for severe chromosomal disorders in a fetus; and Prolaris, a RNA expression test for assessing the aggressiveness of prostate cancer. Further, it provides EndoPredict, a RNA expression test for assessing the aggressiveness of breast cancer; myPath Melanoma, a RNA expression test for diagnosing melanoma; and myChoice CDx, a companion diagnostic to measure three modes of homologous recombination deficiency comprising loss of heterozygosity, telomeric allelic imbalance, and large-scale state transitions in cancer cells. Additionally, the company offers biomarker discovery, and pharmaceutical and clinical services to the pharmaceutical, biotechnology, and medical research industries; and operates an internal medicine emergency hospital primarily for internal medicine and hemodialysis. It has a a strategic collaboration with Illumina, Inc. Myriad Genetics, Inc. was founded in 1991 and is headquartered in Salt Lake City, Utah.
Last Close
6.555
Volume
600
Current Price
6.555
Last Updated
2026-01-08T14:12:54.441Z
Ipo Date
-
Market Cap
47994460800
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
205700000
Cost Of Revenue
61900000
Gross Profit
143800000
Operating Expenses
167100000
Operating Income
-23300000
Interest Expense
3800000
Pretax Income
-26200000
Net Income
-27400000
Eps
-0.29430719656283566
Dividends Per Share
-
Shares Outstanding
74762000
Income Tax Expense
1200000
EBITDA
-9800000
Operating Margin
-11.327175498298493
Total Other Income Expense Net
-2900000
Cash
145400000
Short Term Investments
-
Receivables
118000000
Inventories
31600000
Total Current Assets
344800000
Property Plant Equipment
162000000
Total Assets
728100000
Payables
31800000
Short Term Debt
15800000
Long Term Debt
-
Total Liabilities
355300000
Equity
372800000
Bs_currency_symbol
-
Depreciation
12600000
Change In Working Capital
21400000
Cash From Operations
21100000
Capital Expenditures
2800000
Cash From Investing
-6200000
Cash From Financing
56200000
Net Change In Cash
71100000
Cf_currency_symbol
-
PE
-
PB
1.636991684549356
ROE
-7.349785407725322
ROA
-3.763219338003022
FCF
18300000
Fcf Percent
0.08896451142440447
Piotroski FScore
2
Health Score
39
Deep Value Investing Score
4
Defensive Investing Score
6.5
Dividend Investing Score
3
Economic Moat Investing Score
5.8
Garp Investing Score
3.5
Growth Investing Score
2.5
Momentum Investing Score
3
Net Net Investing Score
4
Quality Investing Score
4
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
205700000
Quarters > 0 > income Statement > cost Of Revenue
61900000
Quarters > 0 > income Statement > gross Profit
143800000
Quarters > 0 > income Statement > operating Expenses
167100000
Quarters > 0 > income Statement > operating Income
-23300000
Quarters > 0 > income Statement > interest Expense
3800000
Quarters > 0 > income Statement > pretax Income
-26200000
Quarters > 0 > income Statement > net Income
-27400000
Quarters > 0 > income Statement > eps
-0.29430719656283566
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
93100000
Quarters > 0 > income Statement > income Tax Expense
1200000
Quarters > 0 > income Statement > EBITDA
-9800000
Quarters > 0 > income Statement > operating Margin
-11.327175498298493
Quarters > 0 > income Statement > total Other Income Expense Net
-2900000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
145400000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
118000000
Quarters > 0 > balance Sheet > inventories
31600000
Quarters > 0 > balance Sheet > total Current Assets
344800000
Quarters > 0 > balance Sheet > property Plant Equipment
162000000
Quarters > 0 > balance Sheet > total Assets
728100000
Quarters > 0 > balance Sheet > payables
31800000
Quarters > 0 > balance Sheet > short Term Debt
15800000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
355300000
Quarters > 0 > balance Sheet > equity
372800000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-27400000
Quarters > 0 > cash Flow > depreciation
12600000
Quarters > 0 > cash Flow > change In Working Capital
21400000
Quarters > 0 > cash Flow > cash From Operations
21100000
Quarters > 0 > cash Flow > capital Expenditures
2800000
Quarters > 0 > cash Flow > cash From Investing
-6200000
Quarters > 0 > cash Flow > cash From Financing
56200000
Quarters > 0 > cash Flow > net Change In Cash
71100000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.29430719656283566
Quarters > 0 > ratios > PB
1.636991684549356
Quarters > 0 > ratios > ROE
-7.349785407725322
Quarters > 0 > ratios > ROA
-3.763219338003022
Quarters > 0 > ratios > FCF
18300000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.08896451142440447
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
213100000
Quarters > 1 > income Statement > cost Of Revenue
61300000
Quarters > 1 > income Statement > gross Profit
151800000
Quarters > 1 > income Statement > operating Expenses
481000000
Quarters > 1 > income Statement > operating Income
-329200000
Quarters > 1 > income Statement > interest Expense
1500000
Quarters > 1 > income Statement > pretax Income
-330600000
Quarters > 1 > income Statement > net Income
-330500000
Quarters > 1 > income Statement > eps
-3.572972972972973
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
92500000
Quarters > 1 > income Statement > income Tax Expense
-100000
Quarters > 1 > income Statement > EBITDA
-315000000
Quarters > 1 > income Statement > operating Margin
-154.48146410136084
Quarters > 1 > income Statement > total Other Income Expense Net
-1400000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
74400000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
137000000
Quarters > 1 > balance Sheet > inventories
28700000
Quarters > 1 > balance Sheet > total Current Assets
284300000
Quarters > 1 > balance Sheet > property Plant Equipment
164200000
Quarters > 1 > balance Sheet > total Assets
677300000
Quarters > 1 > balance Sheet > payables
30900000
Quarters > 1 > balance Sheet > short Term Debt
68400000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
289200000
Quarters > 1 > balance Sheet > equity
388100000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-330500000
Quarters > 1 > cash Flow > depreciation
14100000
Quarters > 1 > cash Flow > change In Working Capital
-27000000
Quarters > 1 > cash Flow > cash From Operations
-13600000
Quarters > 1 > cash Flow > capital Expenditures
6900000
Quarters > 1 > cash Flow > cash From Investing
-6900000
Quarters > 1 > cash Flow > cash From Financing
2600000
Quarters > 1 > cash Flow > net Change In Cash
-17300000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-3.572972972972973
Quarters > 1 > ratios > PB
1.5623228549342951
Quarters > 1 > ratios > ROE
-85.15846431332132
Quarters > 1 > ratios > ROA
-48.79669275062749
Quarters > 1 > ratios > FCF
-20500000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.09619896762083528
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
195900000
Quarters > 2 > income Statement > cost Of Revenue
61700000
Quarters > 2 > income Statement > gross Profit
134200000
Quarters > 2 > income Statement > operating Expenses
163200000
Quarters > 2 > income Statement > operating Income
-29000000
Quarters > 2 > income Statement > interest Expense
800000
Quarters > 2 > income Statement > pretax Income
-29400000
Quarters > 2 > income Statement > net Income
-100000
Quarters > 2 > income Statement > eps
-0.0010940919037199124
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
91400000
Quarters > 2 > income Statement > income Tax Expense
-29300000
Quarters > 2 > income Statement > EBITDA
-14200000
Quarters > 2 > income Statement > operating Margin
-14.803471158754466
Quarters > 2 > income Statement > total Other Income Expense Net
-400000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
91800000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
120400000
Quarters > 2 > balance Sheet > inventories
28300000
Quarters > 2 > balance Sheet > total Current Assets
287200000
Quarters > 2 > balance Sheet > property Plant Equipment
167400000
Quarters > 2 > balance Sheet > total Assets
1006100000
Quarters > 2 > balance Sheet > payables
28100000
Quarters > 2 > balance Sheet > short Term Debt
10900000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
301200000
Quarters > 2 > balance Sheet > equity
704900000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-100000
Quarters > 2 > cash Flow > depreciation
14400000
Quarters > 2 > cash Flow > change In Working Capital
-12100000
Quarters > 2 > cash Flow > cash From Operations
-16300000
Quarters > 2 > cash Flow > capital Expenditures
8300000
Quarters > 2 > cash Flow > cash From Investing
-8300000
Quarters > 2 > cash Flow > cash From Financing
13600000
Quarters > 2 > cash Flow > net Change In Cash
-10900000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.0010940919037199124
Quarters > 2 > ratios > PB
0.8499460916442048
Quarters > 2 > ratios > ROE
-0.014186409419775853
Quarters > 2 > ratios > ROA
-0.009939369843951894
Quarters > 2 > ratios > FCF
-24600000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-0.12557427258805512
Quarters > 2 > health Score
33
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
210600000
Quarters > 3 > income Statement > cost Of Revenue
59700000
Quarters > 3 > income Statement > gross Profit
150900000
Quarters > 3 > income Statement > operating Expenses
189900000
Quarters > 3 > income Statement > operating Income
-39000000
Quarters > 3 > income Statement > interest Expense
700000
Quarters > 3 > income Statement > pretax Income
-39100000
Quarters > 3 > income Statement > net Income
-42500000
Quarters > 3 > income Statement > eps
-0.4665203073545554
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
91100000
Quarters > 3 > income Statement > income Tax Expense
3400000
Quarters > 3 > income Statement > EBITDA
-23600000
Quarters > 3 > income Statement > operating Margin
-18.51851851851852
Quarters > 3 > income Statement > total Other Income Expense Net
-100000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
102400000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
121200000
Quarters > 3 > balance Sheet > inventories
27500000
Quarters > 3 > balance Sheet > total Current Assets
298000000
Quarters > 3 > balance Sheet > property Plant Equipment
172400000
Quarters > 3 > balance Sheet > total Assets
1027600000
Quarters > 3 > balance Sheet > payables
32300000
Quarters > 3 > balance Sheet > short Term Debt
12800000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
326500000
Quarters > 3 > balance Sheet > equity
701100000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-42500000
Quarters > 3 > cash Flow > depreciation
14800000
Quarters > 3 > cash Flow > change In Working Capital
-24200000
Quarters > 3 > cash Flow > cash From Operations
6600000
Quarters > 3 > cash Flow > capital Expenditures
5900000
Quarters > 3 > cash Flow > cash From Investing
-5900000
Quarters > 3 > cash Flow > cash From Financing
2100000
Quarters > 3 > cash Flow > net Change In Cash
2100000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.4665203073545554
Quarters > 3 > ratios > PB
0.8517479674796747
Quarters > 3 > ratios > ROE
-6.061902724290401
Quarters > 3 > ratios > ROA
-4.135850525496302
Quarters > 3 > ratios > FCF
700000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.0033238366571699905
Quarters > 3 > health Score
33
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
837600000
Annuals > 0 > income Statement > cost Of Revenue
252200000
Annuals > 0 > income Statement > gross Profit
585400000
Annuals > 0 > income Statement > operating Expenses
708900000
Annuals > 0 > income Statement > operating Income
-123500000
Annuals > 0 > income Statement > interest Expense
2800000
Annuals > 0 > income Statement > pretax Income
-123500000
Annuals > 0 > income Statement > net Income
-127300000
Annuals > 0 > income Statement > eps
-1.4050772626931567
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
90600000
Annuals > 0 > income Statement > income Tax Expense
3800000
Annuals > 0 > income Statement > EBITDA
-59500000
Annuals > 0 > income Statement > operating Margin
-14.744508118433618
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
102400000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
121200000
Annuals > 0 > balance Sheet > inventories
27500000
Annuals > 0 > balance Sheet > total Current Assets
298000000
Annuals > 0 > balance Sheet > property Plant Equipment
172400000
Annuals > 0 > balance Sheet > total Assets
1027600000
Annuals > 0 > balance Sheet > payables
32300000
Annuals > 0 > balance Sheet > short Term Debt
12800000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
326500000
Annuals > 0 > balance Sheet > equity
701100000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-127300000
Annuals > 0 > cash Flow > depreciation
61200000
Annuals > 0 > cash Flow > change In Working Capital
-54400000
Annuals > 0 > cash Flow > cash From Operations
-8700000
Annuals > 0 > cash Flow > capital Expenditures
29700000
Annuals > 0 > cash Flow > cash From Investing
-11900000
Annuals > 0 > cash Flow > cash From Financing
-7400000
Annuals > 0 > cash Flow > net Change In Cash
-29000000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-1.4050772626931567
Annuals > 0 > ratios > PB
0.8470731707317073
Annuals > 0 > ratios > ROE
-18.157181571815716
Annuals > 0 > ratios > ROA
-12.38808875048657
Annuals > 0 > ratios > FCF
-38400000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.045845272206303724
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
753200000
Annuals > 1 > income Statement > cost Of Revenue
236200000
Annuals > 1 > income Statement > gross Profit
517000000
Annuals > 1 > income Statement > operating Expenses
774400000
Annuals > 1 > income Statement > operating Income
-257400000
Annuals > 1 > income Statement > interest Expense
2900000
Annuals > 1 > income Statement > pretax Income
-262200000
Annuals > 1 > income Statement > net Income
-263300000
Annuals > 1 > income Statement > eps
-3.179951690821256
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
82800000
Annuals > 1 > income Statement > income Tax Expense
1100000
Annuals > 1 > income Statement > EBITDA
-197400000
Annuals > 1 > income Statement > operating Margin
-34.17419012214552
Annuals > 1 > income Statement > total Other Income Expense Net
-4800000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
132100000
Annuals > 1 > balance Sheet > short Term Investments
8800000
Annuals > 1 > balance Sheet > receivables
114300000
Annuals > 1 > balance Sheet > inventories
22000000
Annuals > 1 > balance Sheet > total Current Assets
313600000
Annuals > 1 > balance Sheet > property Plant Equipment
180600000
Annuals > 1 > balance Sheet > total Assets
1146500000
Annuals > 1 > balance Sheet > payables
25800000
Annuals > 1 > balance Sheet > short Term Debt
16200000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
363300000
Annuals > 1 > balance Sheet > equity
783200000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-263300000
Annuals > 1 > cash Flow > depreciation
61900000
Annuals > 1 > cash Flow > change In Working Capital
27000000
Annuals > 1 > cash Flow > cash From Operations
-110900000
Annuals > 1 > cash Flow > capital Expenditures
73300000
Annuals > 1 > cash Flow > cash From Investing
31900000
Annuals > 1 > cash Flow > cash From Financing
152900000
Annuals > 1 > cash Flow > net Change In Cash
74500000
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
-3.179951690821256
Annuals > 1 > ratios > PB
0.6929954034729315
Annuals > 1 > ratios > ROE
-33.61848825331971
Annuals > 1 > ratios > ROA
-22.965547317924116
Annuals > 1 > ratios > FCF
-184200000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.24455655868295273
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
678400000
Annuals > 2 > income Statement > cost Of Revenue
202000000
Annuals > 2 > income Statement > gross Profit
476400000
Annuals > 2 > income Statement > operating Expenses
617000000
Annuals > 2 > income Statement > operating Income
-140600000
Annuals > 2 > income Statement > interest Expense
3200000
Annuals > 2 > income Statement > pretax Income
-140600000
Annuals > 2 > income Statement > net Income
-112000000
Annuals > 2 > income Statement > eps
-1.3895781637717122
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
80600000
Annuals > 2 > income Statement > income Tax Expense
-28600000
Annuals > 2 > income Statement > EBITDA
-84700000
Annuals > 2 > income Statement > operating Margin
-20.725235849056602
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
56900000
Annuals > 2 > balance Sheet > short Term Investments
58000000
Annuals > 2 > balance Sheet > receivables
101600000
Annuals > 2 > balance Sheet > inventories
20100000
Annuals > 2 > balance Sheet > total Current Assets
274600000
Annuals > 2 > balance Sheet > property Plant Equipment
187300000
Annuals > 2 > balance Sheet > total Assets
1198700000
Annuals > 2 > balance Sheet > payables
28800000
Annuals > 2 > balance Sheet > short Term Debt
14100000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
312900000
Annuals > 2 > balance Sheet > equity
885800000
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-112000000
Annuals > 2 > cash Flow > depreciation
52700000
Annuals > 2 > cash Flow > change In Working Capital
-83500000
Annuals > 2 > cash Flow > cash From Operations
-106300000
Annuals > 2 > cash Flow > capital Expenditures
45300000
Annuals > 2 > cash Flow > cash From Investing
-77500000
Annuals > 2 > cash Flow > cash From Financing
-8000000
Annuals > 2 > cash Flow > net Change In Cash
-192400000
Annuals > 2 > cash Flow > currency_symbol
-
Annuals > 2 > ratios > PE
-1.3895781637717122
Annuals > 2 > ratios > PB
0.5964472792955521
Annuals > 2 > ratios > ROE
-12.643937683449987
Annuals > 2 > ratios > ROA
-9.34345541002753
Annuals > 2 > ratios > FCF
-151600000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.22346698113207547
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
690600000
Annuals > 3 > income Statement > cost Of Revenue
197600000
Annuals > 3 > income Statement > gross Profit
493000000
Annuals > 3 > income Statement > operating Expenses
683500000
Annuals > 3 > income Statement > operating Income
-190500000
Annuals > 3 > income Statement > interest Expense
6600000
Annuals > 3 > income Statement > pretax Income
-57100000
Annuals > 3 > income Statement > net Income
-27200000
Annuals > 3 > income Statement > eps
-0.3487179487179487
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
78000000
Annuals > 3 > income Statement > income Tax Expense
-29900000
Annuals > 3 > income Statement > EBITDA
12300000
Annuals > 3 > income Statement > operating Margin
-27.58470894874023
Annuals > 3 > income Statement > total Other Income Expense Net
133400000
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
258400000
Annuals > 3 > balance Sheet > short Term Investments
81400000
Annuals > 3 > balance Sheet > receivables
91300000
Annuals > 3 > balance Sheet > inventories
15300000
Annuals > 3 > balance Sheet > total Current Assets
484800000
Annuals > 3 > balance Sheet > property Plant Equipment
125300000
Annuals > 3 > balance Sheet > total Assets
1320700000
Annuals > 3 > balance Sheet > payables
29600000
Annuals > 3 > balance Sheet > short Term Debt
13000000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
352900000
Annuals > 3 > balance Sheet > equity
967800000
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-27200000
Annuals > 3 > cash Flow > depreciation
62800000
Annuals > 3 > cash Flow > change In Working Capital
120800000
Annuals > 3 > cash Flow > cash From Operations
18600000
Annuals > 3 > cash Flow > capital Expenditures
18000000
Annuals > 3 > cash Flow > cash From Investing
274400000
Annuals > 3 > cash Flow > cash From Financing
-150600000
Annuals > 3 > cash Flow > net Change In Cash
141800000
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-0.3487179487179487
Annuals > 3 > ratios > PB
0.5283013019218846
Annuals > 3 > ratios > ROE
-2.81049803678446
Annuals > 3 > ratios > ROA
-2.059513894147043
Annuals > 3 > ratios > FCF
600000
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
0.0008688097306689834
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.29430719656283566
Valuation > metrics > PB
1.636991684549356
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-7.349785407725322
Profitability > metrics > ROA
-7.9466357308584685
Profitability > metrics > Net Margin
-0.1332036947010209
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.9530579399141631
Risk > metrics > Interest Coverage
-6.131578947368421
Risk > final Score
23
Risk > verdict
High
Liquidity > metrics > Current Ratio
7.243697478991597
Liquidity > metrics > Quick Ratio
6.579831932773109
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-830
Prev Risks > 1
-85
Prev Risks > 2
-163
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:13:52.352Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-23
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-0.02
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-09-30
Earnings History > 1 > report Date
2021-11-02
Earnings History > 1 > date
2021-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
0.3018
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2021-06-30
Earnings History > 2 > report Date
2021-08-03
Earnings History > 2 > date
2021-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0609
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2021-03-31
Earnings History > 3 > report Date
2021-05-03
Earnings History > 3 > date
2021-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.5197
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-06-30
Earnings History > 4 > report Date
2020-06-30
Earnings History > 4 > date
2020-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.7426
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-03-31
Earnings History > 5 > report Date
2020-03-31
Earnings History > 5 > date
2020-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-1.5463
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-12-31
Earnings History > 6 > report Date
2019-12-31
Earnings History > 6 > date
2019-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.1116
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-09-30
Earnings History > 7 > report Date
2019-09-30
Earnings History > 7 > date
2019-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.2795
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-06-30
Earnings History > 8 > report Date
2019-06-30
Earnings History > 8 > date
2019-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0572
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-03-31
Earnings History > 9 > report Date
2019-03-31
Earnings History > 9 > date
2019-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0.0921
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-12-31
Earnings History > 10 > report Date
2018-12-31
Earnings History > 10 > date
2018-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.034
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-09-30
Earnings History > 11 > report Date
2018-09-30
Earnings History > 11 > date
2018-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0096
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-06-30
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0.1797
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-03-31
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.1575
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Myriad Genetics, Inc., a molecular diagnostic company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and internationally. The company offers myRisk Hereditary Cancer, a DNA sequencing test for hereditary cancers; BRACAnalysis, a DNA sequencing test to assess the risk of developing breast and ovarian cancer; and riskScore, a personalized medicine tool. It also provides BRACAnalysis CDx, a DNA sequencing test for use in identifying ovarian and HER2 negative metastatic breast cancer patients with deleterious or suspected deleterious germline; GeneSight, a DNA genotyping test to aid psychotropic drug selection for depressed patients; and Vectra, a protein quantification test for assessing the disease activity of rheumatoid arthritis. In addition, the company offers Foresight, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; Prequel, a non-invasive prenatal screening test to screen for severe chromosomal disorders in a fetus; and Prolaris, a RNA expression test for assessing the aggressiveness of prostate cancer. Further, it provides EndoPredict, a RNA expression test for assessing the aggressiveness of breast cancer; myPath Melanoma, a RNA expression test for diagnosing melanoma; and myChoice CDx, a companion diagnostic to measure three modes of homologous recombination deficiency comprising loss of heterozygosity, telomeric allelic imbalance, and large-scale state transitions in cancer cells. Additionally, the company offers biomarker discovery, and pharmaceutical and clinical services to the pharmaceutical, biotechnology, and medical research industries; and operates an internal medicine emergency hospital primarily for internal medicine and hemodialysis. It has a a strategic collaboration with Illumina, Inc. Myriad Genetics, Inc. was founded in 1991 and is headquartered in Salt Lake City, Utah.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Myriad Genetics Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.02
Date
2021-09-30
EPS Actual
0.3018
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.